DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0013604 | Edema | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C0020598 | Hypocalcemia | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C0035305 | Retinal Detachment | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C0013274 | Patent ductus arteriosus | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C0848558 | Hypospadias | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C1837396 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C4317295 | Congenital disorder of glycosylation type 1s | ALG12 | 79087 | ALG12 alpha-1,6-mannosyltransferase | Q9BV10 |
C3714756 | Intellectual Disability | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0038379 | Strabismus | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C3150913 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0036439 | Scoliosis, unspecified | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0282577 | Congenital Disorders of Glycosylation | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C1384666 | hearing impairment | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0025521 | Inborn Errors of Metabolism | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0025958 | Microcephaly | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0235946 | Cerebral atrophy | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0036572 | Seizures | ALG11 | 440138 | ALG11 alpha-1,2-mannosyltransferase | Q2TAA5 |
C0023976 | Long QT Syndrome | ALG10B | 144245 | ALG10 alpha-1,2-glucosyltransferase B | Q5I7T1 |
C0003811 | Cardiac Arrhythmia | ALG10B | 144245 | ALG10 alpha-1,2-glucosyltransferase B | Q5I7T1 |
C3150943 | Long Qt Syndrome 2 | ALG10B | 144245 | ALG10 alpha-1,2-glucosyltransferase B | Q5I7T1 |
C0003811 | Cardiac Arrhythmia | ALG10 | 84920 | ALG10 alpha-1,2-glucosyltransferase | Q5BKT4 |
C0023976 | Long QT Syndrome | ALG10 | 84920 | ALG10 alpha-1,2-glucosyltransferase | Q5BKT4 |
C3150943 | Long Qt Syndrome 2 | ALG10 | 84920 | ALG10 alpha-1,2-glucosyltransferase | Q5BKT4 |
C0019196 | Hepatitis C | ALG10 | 84920 | ALG10 alpha-1,2-glucosyltransferase | Q5BKT4 |
C2931005 | Congenital disorder of glycosylation type 1K | ALG1 | 56052 | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | Q9BT22 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024